Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Before treatment (baseline) Typical starting concerns: dullness, uneven tone, hyperpigmentation, dark spots, or tired-looking skin
19(8):969-988 Peptide Sequence: Gly-His-Lys(Cu2+) Hong Y, Downey T, Eu KW, Koh PK, Cheah PY (Department f Colorectal Surgery, Singapore General Hospital, Singapore, 169608,Singapore) "A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics" In Clin Exp Metastasis
These biomarkers elucidate underlying resistance mechanisms by identifying resistance-prone subpopulations, metabolic adaptations, and key microenvironmental cues
MODIFIED GRF (1-29) PEPTIDE 2MG VIAL $28.99 MODIFIED GRF (1-29) is sold for laboratory research use only
4,207,208 The resultant neuronal hyperexcitability and microglial activation lead to chronic neuropathic pain
US$ 20.13
US$ 26.12
US$ 26.33
US$ 21.85
US$ 27.80
